false
ar,be,bn,zh-CN,zh-TW,en,fr,de,hi,it,ja,ko,pt,ru,es,sw,vi
Skip Navigation Links
EDU360 Home
IGCS Website
IGCS Profile
Education360 Information
Membership
FAQ
International Journal of Gynecological Cancer
Menu
EDU360 Home
IGCS Website
IGCS Profile
Education360 Information
Membership
FAQ
International Journal of Gynecological Cancer
Hamburger Menu
Catalog
Calendar
Help
Login
User Login
Continue with Google
OR
Login Name
Required
Password
Required
Logging In…
Create Account
Forgot Password
ADVERTISEMENT
Search
select
10 miles
50 miles
100 miles
250 miles
500 miles
Search by map
Search Result for:
Advances & Updates
Browse:
Education by Topic
Surgical Education (11)
Cervical Cancer (12)
Ovarian Cancer (11)
Uterine Cancer (13)
Vaginal & Vulvar Cancer (2)
Pathology (4)
Early Career (5)
Radiation Oncology (5)
Palliative Care (2)
Nursing (2)
Breast (3)
Literature - In The Know (1)
Recently Recorded Webinars
Advances & Updates (21)
Surgical Films (7)
Palliative Care (1)
Nursing (1)
Pathology (2)
Advocacy (1)
Certificate Programs
Evidence-Based Medicine (1)
Nursing (1)
Palliative Care (1)
Preinvasive Disease (1)
Translated Offerings
Spanish (9)
Portuguese (4)
Annual Global Meeting
2022 (1)
2021 (1)
2020 (1)
×
Sort By
select
Price: Low to High
Price: High to Low
Popularity
Most Recent
Oldest First
Alphabetical (A-Z)
Alphabetical (Z-A)
Most Relevant
Catalog Display Mode
Catalog Display Mode
Study 309/Keynote-775: A Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib with Pembrolizumab vs Treatment of Physician’s Choice in Advanced Endometrial Cancer
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Study 309/Keynote-775: A Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib with Pembrolizumab vs Treatment of Physician’s Choice in Advanced Endometrial Cancer
Free
Endometrial Cancer Tumor Board: Matching the right therapy to the right patient
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Endometrial Cancer Tumor Board: Matching the right therapy to the right patient
Free
Folate Alpha Targeting: Exciting New Options for Platinum Resistance Ovarian Cancer Patients
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Folate Alpha Targeting: Exciting New Options for Platinum Resistance Ovarian Cancer Patients
Free
Tumor Board: How new data in cervical cancer effects second-line treatment options
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Tumor Board: How new data in cervical cancer effects second-line treatment options
Free
Treatment Options for Platinum Resistant Ovarian Cancer
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Treatment Options for Platinum Resistant Ovarian Cancer
Free
Second-Line Treatment Options for Patients with Recurrent Cervical Cancer. Review of Current Treatment and Future Directions
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Second-Line Treatment Options for Patients with Recurrent Cervical Cancer. Review of Current Treatment and Future Directions
Free
Overall Survival Data with PARP Inhibitor: Myth vs. Reality
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Overall Survival Data with PARP Inhibitor: Myth vs. Reality
Free
Multidisciplinary Approach to Treating Advanced Endometrial Cancer
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Multidisciplinary Approach to Treating Advanced Endometrial Cancer
Free
New Options in Platinum Resistant Ovarian Cancer
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
New Options in Platinum Resistant Ovarian Cancer
Free
Phase III MIRASOL (GOG 3045/ENGOT-ov55) Study Results
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Phase III MIRASOL (GOG 3045/ENGOT-ov55) Study Results
Free
Novel combinations for treatment of recurrent cervical cancer
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Novel combinations for treatment of recurrent cervical cancer
Free
How current maintenance therapy is changing in ovarian cancer and what’s next
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
How current maintenance therapy is changing in ovarian cancer and what’s next
Free
Encouraging Results Seen in Patients with Heavily Pre-Treated Low-Grade Serous Ovarian
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Encouraging Results Seen in Patients with Heavily Pre-Treated Low-Grade Serous Ovarian
Free
Changing the standard of care in 2nd line recurrent cervical cancer
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Changing the standard of care in 2nd line recurrent cervical cancer
Free
Mismatch repair endometrial cancer, what to do at first recurrence and beyond?
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Mismatch repair endometrial cancer, what to do at first recurrence and beyond?
Free
An Evolving Frontier: Endometrial Cancer Treatment
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
An Evolving Frontier: Endometrial Cancer Treatment
Free
Refresher on Selecting Genetic Testing for Ovarian Cancer Treatment Decisions
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Refresher on Selecting Genetic Testing for Ovarian Cancer Treatment Decisions
Free
Newly Opened Phase 3 Study for Low Grade Serous Ovarian Cancer
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Newly Opened Phase 3 Study for Low Grade Serous Ovarian Cancer
Free
Immunotherapy and its impact on overall survival in patients with recurrent endometrial cancer
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Immunotherapy and its impact on overall survival in patients with recurrent endometrial cancer
Free
Selinexor in Maintenance Therapy After Systemic Therapy for Patients with p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma: XPORT-042 - Trial in Progress
On-Demand
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Selinexor in Maintenance Therapy After Systemic Therapy for Patients with p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma: XPORT-042 - Trial in Progress
Free
Course
1
to
20
of
21
Contact
education@igcs.org
for assistance.
×